Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer

Published:2013-04 Issue:6 Volume:49 Page:1254-1263
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van der Burg M.E.L.,Vergote I.,Onstenk W.,Boere I.A.,Leunen K.,van Montfort C.A.G.M.,van Doorn H.C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996

2. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Parmar;Lancet,2003

3. Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse;Pujade-Lauraine;J Clin Oncol,2010

4. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG;Pfisterer;J Clin Oncol,2006

5. Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance;See;Int J Gynecol Cancer,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer;2024-02-05

2. An evaluation of cancer aging research group (CARG) score to predict chemotherapy toxicity in older Iranian patients with cancer;Oncologie;2023-05-01

3. CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer;International Journal of Gynecologic Cancer;2023-04-17

4. Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis;2022-07-15

5. The systemic treatment of recurrent ovarian cancer revisited;Annals of Oncology;2021-06